跳至主要内容
临床试验/NL-OMON46960
NL-OMON46960已完成不适用

A Feasibility Study to Assess Safety and Efficacy of the Transapical and Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients with Symptomatic Severe Aortic Stenosis (AS) (CA-0001)/ Symptomatic Severe Aortic Regurgitation (AR) (CA-0002) - JenaValve AS/AR Feasibility Study

JenaValve Technology, Inc.0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Adult patients with symptomatic severe aortic stenosis or symptomatic severe aortic regurgitation who are at high risk for surgical aortic valve replacement

排除标准

  • Congenital uni- or bicuspid aortic valve morphology, previous prosthetic aortic valve implant, mitral regurgitation greater than moderate

研究者

相似试验

A Feasibility Study to Assess Safety and Efficacy of... | 临床试验